BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 18459760)

  • 1. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
    Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
    J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homology model adjustment and ligand screening with a pseudoreceptor of the human histamine H4 receptor.
    Tanrikulu Y; Proschak E; Werner T; Geppert T; Todoroff N; Klenner A; Kottke T; Sander K; Schneider E; Seifert R; Stark H; Clark T; Schneider G
    ChemMedChem; 2009 May; 4(5):820-7. PubMed ID: 19343764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first potent and selective non-imidazole human histamine H4 receptor antagonists.
    Jablonowski JA; Grice CA; Chai W; Dvorak CA; Venable JD; Kwok AK; Ly KS; Wei J; Baker SM; Desai PJ; Jiang W; Wilson SJ; Thurmond RL; Karlsson L; Edwards JP; Lovenberg TW; Carruthers NI
    J Med Chem; 2003 Sep; 46(19):3957-60. PubMed ID: 12954048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of 2-arylbenzimidazoles as potent human histamine H4 receptor ligands.
    Lee-Dutra A; Arienti KL; Buzard DJ; Hack MD; Khatuya H; Desai PJ; Nguyen S; Thurmond RL; Karlsson L; Edwards JP; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6043-8. PubMed ID: 16990005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
    Schneider EH; Strasser A; Thurmond RL; Seifert R
    J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delineation of agonist binding to the human histamine H4 receptor using mutational analysis, homology modeling, and ab initio calculations.
    Jongejan A; Lim HD; Smits RA; de Esch IJ; Haaksma E; Leurs R
    J Chem Inf Model; 2008 Jul; 48(7):1455-63. PubMed ID: 18553960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular determinants of ligand binding modes in the histamine H(4) receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies.
    Istyastono EP; Nijmeijer S; Lim HD; van de Stolpe A; Roumen L; Kooistra AJ; Vischer HF; de Esch IJ; Leurs R; de Graaf C
    J Med Chem; 2011 Dec; 54(23):8136-47. PubMed ID: 22003888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H4 receptor ligands and their potential therapeutic applications.
    Kiss R; Keseru GM
    Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docking and MD study of histamine H4R based on the crystal structure of H1R.
    Feng Z; Hou T; Li Y
    J Mol Graph Model; 2013 Feb; 39():1-12. PubMed ID: 23220277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
    Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
    Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationships of cyanoguanidine-type and structurally related histamine H4 receptor agonists.
    Igel P; Geyer R; Strasser A; Dove S; Seifert R; Buschauer A
    J Med Chem; 2009 Oct; 52(20):6297-313. PubMed ID: 19791743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of nanomolar ligands with novel scaffolds for the histamine H4 receptor by virtual screening.
    Levoin N; Labeeuw O; Billot X; Calmels T; Danvy D; Krief S; Berrebi-Bertrand I; Lecomte JM; Schwartz JC; Capet M
    Eur J Med Chem; 2017 Jan; 125():565-572. PubMed ID: 27718472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands.
    Schreeb A; Walter M; Odadzic D; Schwed JS; Weizel L; Stark H
    Pharmazie; 2013 Jul; 68(7):521-5. PubMed ID: 23923631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of conformationally constrained histamine H(3) receptor agonists.
    Kitbunnadaj R; Zuiderveld OP; De Esch IJ; Vollinga RC; Bakker R; Lutz M; Spek AL; Cavoy E; Deltent MF; Menge WM; Timmerman H; Leurs R
    J Med Chem; 2003 Dec; 46(25):5445-57. PubMed ID: 14640553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
    Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
    Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
    J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bispyrimidines as potent histamine H(4) receptor ligands: delineation of structure-activity relationships and detailed H(4) receptor binding mode.
    Engelhardt H; Schultes S; de Graaf C; Nijmeijer S; Vischer HF; Zuiderveld OP; Dobler J; Stachurski K; Mayer M; Arnhof H; Scharn D; Haaksma EE; de Esch IJ; Leurs R
    J Med Chem; 2013 Jun; 56(11):4264-76. PubMed ID: 23668417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.